demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
imatinib Aman

1 studies excluded by filtering options 0

5271 Covid-19 HUF, 2021 110risk of bias not avaialble